Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-046929
Filing Date
2024-11-20
Accepted
2024-11-20 07:00:12
Documents
3
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 20901
2 ex99-1.htm EX-99.1 15336
3 ex99-1_001.jpg GRAPHIC 5075
  Complete submission text file 0001493152-24-046929.txt   44503
Mailing Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544
Business Address #08-22 ONE COMMONWEALTH 1 COMMONWEALTH LANE U0 149544 603824911
CytoMed Therapeutics Ltd (Filer) CIK: 0001873093 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41677 | Film No.: 241478258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)